NYSE$DGX
Quest Diagnostics Inc · Q3 2022 earnings
Q3 2022 earnings · · Investor relations
Briefing
Reported a decrease in revenue and EPS due to decline in COVID-19 testing revenues, while base business revenues increased.
Quest Diagnostics reported a decrease in revenue and EPS for Q3 2022 compared to Q3 2021. The decrease was primarily due to a decline in COVID-19 testing revenues. However, the base business revenues increased by 5.1%. The company has raised its outlook for the remainder of 2022 based on this performance.
- Third quarter revenues were $2.49 billion, a 10.4% decrease from 2021.
- Reported diluted EPS was $2.17, a 46.0% decrease from 2021.
- Base business revenues were $2.17 billion, a 5.1% increase from 2021.
- Full year 2022 reported diluted EPS is now expected to be between $8.52 and $8.72.
Headline financials
Revenue & EPS history
Quest Diagnostics · Revenue · Quarterly
$2.49B
Revenue by segment
Quest Diagnostics · $2.38B total across 1 segment · Q2 2022
- Diagnostic information services$2.38B—100.0%
Forward guidance
The company raises its Full Year 2022 guidance.
Tailwinds
- Net revenues between $9.72 billion and $9.86 billion.
- Base business revenues between $8.38 billion and $8.45 billion.
- Base business revenues increase 4.5% to 5.4%.
- COVID-19 testing revenues between $1.34 billion and $1.41 billion.
- Adjusted diluted EPS between $9.75 and $9.95.
Headwinds
- Net revenues decrease (9.9)% to (8.6)%.
- COVID-19 testing revenues decrease (51.6)% to (49.1)%.
- Capital expenditures approximately $400 million.
- Further impacts to earnings related to special items may occur throughout 2022.
- The amount of ETB is dependent upon employee stock option exercises and our stock price, both of which are difficult to predict.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q3 2022
+0.0%
Avg return
Earnings day
+1.2%
Avg return
5 days after
+2.1%
Avg return
30 days after
45%
33 / 73 earnings
Positive
+11.2%
Q1 2019
Best reaction
-9.9%
Q3 2018
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +4.3% | -0.0% | -2.2% | |
| Q4 2025 | +7.4% | +8.2% | +5.0% | |
| Q3 2025 | -3.0% | -4.3% | -1.5% | |
| Q2 2025 | -0.3% | +2.1% | +2.2% | |
| Q1 2025 | +6.8% | +7.4% | +4.8% | |
| Q4 2024 | +5.6% | +5.1% | +11.2% | |
| Q3 2024 | +6.6% | +5.2% | +11.2% | |
| Q2 2024 | -2.3% | -1.2% | +3.7% | |
| Q1 2024 | +5.7% | +3.2% | +7.6% | |
| Q4 2023 | -2.7% | -1.7% | -2.9% | |
| Q3 2023 | +3.3% | +5.1% | +11.8% | |
| Q2 2023 | -7.3% | -6.7% | -8.6% | |
| Q1 2023 | -5.5% | -5.9% | -8.9% | |
| Q4 2022 | -3.9% | -1.8% | -5.3% | |
| Q3 2022 | +8.0% | +13.7% | +15.6% | |
| Q2 2022 | -2.8% | -1.2% | +0.5% | |
| Q1 2022 | -0.9% | -2.7% | +1.9% | |
| Q4 2021 | -1.4% | -1.0% | +1.3% | |
| Q3 2021 | -0.2% | -0.9% | +1.1% | |
| Q2 2021 | +2.7% | +3.1% | +11.9% | |
| Q1 2021 | +0.9% | +1.8% | +1.0% | |
| Q4 2020 | -4.0% | -4.0% | -7.0% | |
| Q3 2020 | +3.5% | +3.5% | +1.6% | |
| Q2 2020 | -3.7% | -4.9% | -9.2% | |
| Q1 2020 | +6.6% | +22.8% | +19.4% | |
| Q4 2019 | +0.0% | +0.5% | -4.2% | |
| Q3 2019 | +0.6% | -1.6% | +2.5% | |
| Q2 2019 | +5.4% | +3.3% | +4.6% | |
| Q1 2019 | +11.2% | +11.9% | +14.6% | |
| Q4 2018 | -2.3% | -2.0% | -1.6% | |
| Q3 2018 | -9.9% | -9.9% | -8.2% | |
| Q2 2018 | -6.3% | -7.1% | -3.6% | |
| Q1 2018 | -2.6% | -1.0% | +1.3% | |
| Q4 2017 | -2.6% | -4.4% | -4.1% | |
| Q3 2017 | +3.3% | +3.5% | +1.1% | |
| Q2 2017 | -1.1% | +0.1% | -2.6% | |
| Q1 2017 | +5.3% | +7.9% | +7.9% | |
| Q4 2016 | +0.9% | +0.0% | +5.9% | |
| Q3 2016 | +0.9% | +0.2% | +3.1% | |
| Q2 2016 | +1.7% | +1.6% | +1.6% | |
| Q1 2016 | +0.8% | — | — | |
| Q4 2015 | -0.1% | — | — | |
| Q3 2015 | -0.3% | — | — | |
| Q2 2015 | +1.2% | — | — | |
| Q1 2015 | -0.6% | — | — | |
| Q4 2014 | +0.7% | — | — | |
| Q3 2014 | +4.2% | — | — | |
| Q2 2014 | +1.4% | — | — | |
| Q1 2014 | -4.2% | — | — | |
| Q4 2013 | -2.5% | — | — | |
| Q3 2013 | -1.4% | — | — | |
| Q2 2013 | -1.3% | — | — | |
| Q1 2013 | -4.4% | — | — | |
| Q4 2012 | -5.5% | — | — | |
| Q3 2012 | -4.5% | — | — | |
| Q2 2012 | -6.8% | — | — | |
| Q1 2012 | -2.4% | — | — | |
| Q4 2010 | +1.0% | — | — | |
| Q4 2011 | +1.0% | — | — | |
| Q3 2011 | +0.4% | — | — | |
| Q2 2011 | -2.1% | — | — | |
| Q1 2011 | +0.2% | — | — | |
| Q3 2010 | +0.1% | — | — | |
| Q2 2010 | +1.7% | — | — | |
| Q1 2010 | -2.6% | — | — | |
| Q1 2009 | -2.6% | — | — | |
| Q4 2007 | +1.8% | — | — | |
| Q4 2009 | +1.8% | — | — | |
| Q3 2009 | -0.1% | — | — | |
| Q3 2008 | -0.1% | — | — | |
| Q2 2009 | -0.6% | — | — | |
| Q4 2008 | -0.6% | — | — | |
| Q2 2008 | -0.6% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro